AzTrials
AzTrials

Acute Respiratory FailureBEAMNCT02902146

Bougie Use in Emergency Airway Management

A study testing Bougie and Endotracheal tube in people with Acute Respiratory Failure, run by Hennepin Healthcare Research Institute at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This prospective, open-label trial randomizes adult patients intubated in the ED with a Macintosh blade to use or not use a bougie for the first intubation attempt. The primary outcome is first pass success. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Acute Respiratory Failure
What is being tested?
Bougie and Endotracheal tube
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
757 participants
Where
1 siteUnited States
Study dates
27 Sep 2016to 20 Aug 2017
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • The patient must be undergoing orotracheal intubation in the ED with a Macintosh blade (using either video or direct laryngoscopy)
  • The patient must be presumed to be 18 years of age or older at the time of enrollment.

Who cannot join

  • Known anatomic distortion of the upper airway or perilaryngeal structures.
  • Prisoner or under arrest
  • Known or suspected to be pregnant, based on the opinion of the treating physician.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Hennepin County Medical Center

    Minneapolis, Minnesota, 55415

Other trials in United States

About this study

This prospective, open-label trial randomizes adult patients intubated in the ED with a Macintosh blade to use or not use a bougie for the first intubation attempt. The primary outcome is first pass success.

Read the detailed description

The primary analysis for all outcomes will be for those with a difficult airway characteristic (defined as any of: cervical immobility, obesity, large tongue, short neck, small mandible, facial or neck trauma, airway edema, blood in the airway, or vomit in the airway).

We will also analyze all outcomes for all patients enrolled, regardless of whether they have a difficult airway characteristic.

We plan to enroll 374 patients with a difficult airway characteristic (DAC). The total enrollment for the trial will be higher, depending on the proportion of patients that have a DAC.

Based on observational data, we aim to detect a 9% absolute difference in first pass success (95% with bougie compared to 86% without the bougie), which requires enrollment of 374 patients with a DAC.

To help achieve balanced randomization for patients with a DAC, patients are stratified into two groups: 1) obese or cervical immobilization present and 2) not obese and no cervical immobilization.

Being tested
Bougie, Endotracheal tube

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BougieDevice

  • Endotracheal tubeDevice

Study groups in NCT02902146
Study groupRoleWhat they receive
BougieActive comparatorOn the first intubation attempt, this arm will attempt to place a bougie into the trachea, followed by an endotracheal tube.
Receives: Device: Bougie
No bougie (endotracheal tube first)Active comparatorOn the first intubation attempt, this arm will attempt to place an endotracheal tube into the trachea directly.
Receives: Device: Endotracheal tube

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Participants With First Pass Success

    First pass success is defined as placement of the endotracheal tube (ETT) into the trachea on the first attempt. An attempt begins when the laryngoscope enters the mouth, and ends if either of the following occur:

    1. the laryngoscope leaves the mouth, regardless of whether an attempt was made to pass the endotracheal tube or bougie.
    2. if the operator cannot intubate the trachea with the first tube device (ETT or bougie), and switches to any other tube device, even if the laryngoscope blade remains in the mouth.

    A patient will be considered to achieve the primary outcome if they are intubated successfully on the first attempt.

    Measured: 5 minutes

Secondary outcomes (4)
  1. First Pass Success Without Hypoxemia

    First pass success without hypoxemia. Hypoxemia is defined as a pulse oximetry value (SpO2) less than 90% at any point during intubation, or a drop of more than 10% from baseline if starting below 90%. The outcome of hypoxemia will be recorded beginning when the first attempt begins and ending one minute after inflation of the ETT cuff.

    A patient will be considered to achieve this outcome if 1) they are intubated successfully on the first attempt, and 2) do not experience hypoxemia on the first attempt.

    Measured: 5 minutes

  2. Time to Intubation (First Attempt)

    Time to intubation will be defined as the time elapsed between the beginning of the intubation attempt to inflation of the ETT cuff when the tube is in the trachea.

    Measured: 5 minutes

  3. Esophageal Intubation

    defined as passage of the ETT into the esophagus, with subsequent ventilation, and then removal. Clinically, esophageal intubation is identified by the absence of end-tidal carbon dioxide, abnormal physical exam, and hypoxia. This does not count passage of the ETT into the esophagus during the attempt if the ETT is removed during the attempt.

    Measured: 5 minutes

  4. Hypoxemia

    Hypoxemia is defined as a pulse oximetry value (SpO2) less than 90% at any point during intubation, or a drop of more than 10% from baseline if starting below 90%. The outcome of hypoxemia will be recorded beginning when the first attempt begins and ending one minute after inflation of the ETT cuff.

    Measured: 5 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Sep 2016 (estimated)
  2. Study start27 Sep 2016
  3. Primary completion20 Aug 2017
  4. Study completion20 Aug 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
757 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02902146
Sponsor's protocol ID
16-4146
Acronym
BEAM
Status last verified
May 2019
First submitted
12 Sep 2016
Last updated
11 Jun 2019
Data monitoring committee
Yes

Publications

  • Driver BE, Prekker ME, Klein LR, Reardon RF, Miner JR, Fagerstrom ET, Cleghorn MR, McGill JW, Cole JB. Effect of Use of a Bougie vs Endotracheal Tube and Stylet on First-Attempt Intubation Success Among Patients With Difficult Airways Undergoing Emergency Intubation: A Randomized Clinical Trial. JAMA. 2018 Jun 5;319(21):2179-2189. doi: 10.1001/jama.2018.6496.

    PubMed 29800096

Questions about this trial

What is this clinical trial studying?

A study testing Bougie and Endotracheal tube in people with Acute Respiratory Failure, run by Hennepin Healthcare Research Institute at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Jun 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 11 Jun 2019). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Participants With First Pass Success (time frame: 5 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02902146, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jun 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in